115 related articles for article (PubMed ID: 7627722)
1. Possible predictive markers of immunotherapy in esophageal cancer: retrospective analysis of a randomized study. The Cooperative Study Group for Esophageal Cancer in Japan.
Ogoshi K; Satou H; Isono K; Mitomi T; Endoh M; Sugita M
Cancer Invest; 1995; 13(4):363-9. PubMed ID: 7627722
[TBL] [Abstract][Full Text] [Related]
2. Immunotherapy for esophageal cancer. A randomized trial in combination with radiotherapy and radiochemotherapy. Cooperative Study Group for Esophageal Cancer in Japan.
Ogoshi K; Satou H; Isono K; Mitomi T; Endoh M; Sugita M
Am J Clin Oncol; 1995 Jun; 18(3):216-22. PubMed ID: 7747709
[TBL] [Abstract][Full Text] [Related]
3. [Evaluation of immunotherapy with PSK in esophageal cancer].
Ogoshi K
Gan To Kagaku Ryoho; 1988 Nov; 15(11):3143-51. PubMed ID: 3056280
[TBL] [Abstract][Full Text] [Related]
4. Immunotherapy and combined assay of serum levels of carcinoembryonic antigen and acute-phase reactants.
Ogoshi K; Miyaji M; Nakamura K; Kondoh Y; Makuuchi H; Tajima T
Cancer Immunol Immunother; 1998 Mar; 46(1):14-20. PubMed ID: 9520287
[TBL] [Abstract][Full Text] [Related]
5. Randomized, controlled study on adjuvant immunochemotherapy with PSK in curatively resected colorectal cancer. The Cooperative Study Group of Surgical Adjuvant Immunochemotherapy for Cancer of Colon and Rectum (Kanagawa).
Mitomi T; Tsuchiya S; Iijima N; Aso K; Suzuki K; Nishiyama K; Amano T; Takahashi T; Murayama N; Oka H
Dis Colon Rectum; 1992 Feb; 35(2):123-30. PubMed ID: 1735313
[TBL] [Abstract][Full Text] [Related]
6. [Clinical effects of PSK on esophageal and gastric cancer patients and usefulness of serum levels of glycoproteins and HLA antigens as prognostic indicators].
Ogoshi K; Mitomi T
Nihon Geka Gakkai Zasshi; 1989 Sep; 90(9):1443-6. PubMed ID: 2586437
[TBL] [Abstract][Full Text] [Related]
7. Effectiveness of immunochemotherapy with PSK, a protein-bound polysaccharide, in colorectal cancer and changes of tumor marker.
Kudo S; Tanaka J; Kashida H; Tamegai Y; Endo S; Yamano HO
Oncol Rep; 2002; 9(3):635-8. PubMed ID: 11956642
[TBL] [Abstract][Full Text] [Related]
8. Immunochemotherapy with PSK and fluoropyrimidines improves long-term prognosis for curatively resected colorectal cancer.
Sakai T; Yamashita Y; Maekawa T; Mikami K; Hoshino S; Shirakusa T
Cancer Biother Radiopharm; 2008 Aug; 23(4):461-7. PubMed ID: 18771350
[TBL] [Abstract][Full Text] [Related]
9. A randomized trial of chemoimmunotherapy of acute nonlymphocytic leukemia in adults using a protein-bound polysaccharide preparation.
Ohno R; Yamada K; Masaoka T; Ohshima T; Amaki I; Hirota Y; Horikoshi N; Horiuchi A; Imai K; Kimura I
Cancer Immunol Immunother; 1984; 18(3):149-54. PubMed ID: 6391658
[TBL] [Abstract][Full Text] [Related]
10. Postoperative adjuvant randomised trial comparing chemoendocrine therapy, chemotherapy and immunotherapy for patients with stage II breast cancer: 5-year results from the Nishinihon Cooperative Study Group of Adjuvant Chemoendocrine Therapy for Breast Cancer (ACETBC) of Japan.
Morimoto T; Ogawa M; Orita K; Sugimachi K; Toge T; Dohi K; Nomura Y; Monden Y; Ogawa N
Eur J Cancer; 1996 Feb; 32A(2):235-42. PubMed ID: 8664034
[TBL] [Abstract][Full Text] [Related]
11. Impact of splenectomy and immunochemotherapy on survival following gastrectomy for carcinoma: covariate interaction with immunosuppressive acidic protein, a serum marker for the host immune system. Tumor Marker Committee for the Study Group of Immunochemotherapy with PSK for Gastric Cancer.
Saji S; Sakamoto J; Teramukai S; Kunieda K; Sugiyama Y; Ohashi Y; Nakazato H
Surg Today; 1999; 29(6):504-10. PubMed ID: 10385364
[TBL] [Abstract][Full Text] [Related]
12. Anticancer effects and mechanisms of polysaccharide-K (PSK): implications of cancer immunotherapy.
Fisher M; Yang LX
Anticancer Res; 2002; 22(3):1737-54. PubMed ID: 12168863
[TBL] [Abstract][Full Text] [Related]
13. [Effect of PSK on recurrence of stage II/III gastric cancer].
Tanaka H; Muguruma K; Kubo N; Amano R; Noda E; Yamada N; Yashiro M; Maeda K; Sawada T; Ohira M; Ishikawa T; Hirakawa K
Gan To Kagaku Ryoho; 2010 Nov; 37(12):2258-60. PubMed ID: 21224540
[TBL] [Abstract][Full Text] [Related]
14. [Effectiveness of multidisciplinary treatment combined with immunotherapy in esophageal cancer--analysis of 287 cases of carcinoma of the thoracic part of the esophagus in Kyushu and Yamaguchi districts].
Sugimachi K; Miyauchi Y; Inutsuka S; Kakegawa T; Nishi M; Tomita M; Koga Y; Ishigami K; Inokuchi K
Gan No Rinsho; 1987 Jun; 33(7):777-83. PubMed ID: 3613103
[TBL] [Abstract][Full Text] [Related]
15. Glycosidically bound sialic acid levels as a predictive marker of postoperative adjuvant therapy in gastric cancer.
Ogoshi K; Kondoh Y; Tajima T; Mitomi T
Cancer Immunol Immunother; 1992; 35(3):175-80. PubMed ID: 1638553
[TBL] [Abstract][Full Text] [Related]
16. Polysaccharide K and Coriolus versicolor extracts for lung cancer: a systematic review.
Fritz H; Kennedy DA; Ishii M; Fergusson D; Fernandes R; Cooley K; Seely D
Integr Cancer Ther; 2015 May; 14(3):201-11. PubMed ID: 25784670
[TBL] [Abstract][Full Text] [Related]
17. Acute-phase reactants as tumor markers.
Schwartz MK
Cancer Invest; 1995; 13(4):444-5. PubMed ID: 7543001
[No Abstract] [Full Text] [Related]
18. Efficacy of immunochemotherapy as adjuvant treatment after curative resection of gastric cancer. Study Group of Immunochemotherapy with PSK for Gastric Cancer.
Nakazato H; Koike A; Saji S; Ogawa N; Sakamoto J
Lancet; 1994 May; 343(8906):1122-6. PubMed ID: 7910230
[TBL] [Abstract][Full Text] [Related]
19. Activation by the protein-bound polysaccharide PSK (krestin) of cytotoxic lymphocytes that act on fresh autologous tumor cells and T24 human urinary bladder transitional carcinoma cell line in patients with urinary bladder cancer.
Mizutani Y; Yoshida O
J Urol; 1991 May; 145(5):1082-7. PubMed ID: 2016797
[TBL] [Abstract][Full Text] [Related]
20. Impact of adjuvant immunochemotherapy using protein-bound polysaccharide-K on overall survival of patients with gastric cancer.
Tanaka H; Muguruma K; Ohira M; Kubo N; Yamashita Y; Maeda K; Sawada T; Hirakawa K
Anticancer Res; 2012 Aug; 32(8):3427-33. PubMed ID: 22843926
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
